An oligonucleotide mixture for improved detection of human papillomavirus genotypes
Cervical cancer (cancer of the uterine cervix) is the second most common cancer among women worldwide with about 470,000 newly diagnosed cases and almost 250,000 deaths every year. The predominant cause for cervical cancer is infection of the cervix with human papillomavirus (HPV), particularly with high-risk HPV genotypes.
The identification of specific HPV genotypes is important, as various HPV genotypes and multiple infections pose different risks to the affected pa-tients. HPV DNA tests are detecting ongoing infections and cervical lesions but their specificity for ab-sence disease is low. In contrast, high viral load was shown to improve the specificity significantly. There is a need for more reliable tests detecting and quantifying different human papillomavirus (HPV) genotypes and, in particular, the high-risk and putative high-risk genotypes.
Further Information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Nerve cells of blind mice retain their visual function
Nerve cells in the retina were analysed at TU Wien (Vienna) using microelectrodes. They show astonishingly stable behavior – good news for retina implants. The retina is often referred to…
State-wide center for quantum science
Karlsruhe Institute of Technology joins IQST as a new partner. The mission of IQST is to further our understanding of nature and develop innovative technologies based on quantum science by…
Newly designed nanomaterial
…shows promise as antimicrobial agent. Rice scientists develop nanocrystals that kill bacteria under visible light. Newly developed halide perovskite nanocrystals (HPNCs) show potential as antimicrobial agents that are stable, effective…